Skip to main content
. 2022 Jun 10;34(18):15313–15348. doi: 10.1007/s00521-022-07424-w

Table 10.

Techniques, attributes, and characteristics of drug discovery-COVID-19 apps

Authors The basic objective Pros Limitations in study Security method? Simulation environments Dataset and Size of Dataset Using TL? Mechanism Application?
Zhang, Wei [115] Using fused graph information and CNN, propose a transformer network for predicting DTIs

-High scalability

-High generalization ability

-High delay No Python

DrugBank dataset

(Large dataset)

No CNN Drug discovery
Amilpur and Bhukya [116] Proposing a generative LSTM model that learned the molecular language and produced unique compounds

High predictability

-Low delay

-Poor flexibility No Keras with Tensorflow

ChEMBL and MOSES

(Large dataset)

Yes LSTM Drug discovery
Deepthi, Jereesh [117] Using a CNN model to rank clinically approved antiviral medicines according to their effectiveness against SARS-CoV-2 -The approach has an AUC of 0.8897, prediction accuracy of 0.8571, and a sensitivity of 0.8394

-Low security

-High delay

No DLEVDA with the python The dataset contains 455 human drug–virus associations between 219 drugs and 34 viruses No CNN + XGBoost COVID-19 drug repurposing
Yang, Bogdan [118] Providing an in silico DL technique for multi-epitope vaccine prediction and design -High accuracy -Low robustness No GalaxyRefne The dataset included 5000 latest known B-cell and 2000 T-cell (Medium size dataset) No CNN Vaccine discovery